Effect of Concomitant Bladder Neck Incision and Urethral Valve Ablation on Surgical Re-intervention Rate for Patients With Posterior Urethral Valve
1 other identifier
interventional
62
1 country
1
Brief Summary
To determine the short-term effects of concurrent valve ablation and bladder neck incision on re-intervention rate for patients with posterior urethral valve.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedFirst Submitted
Initial submission to the registry
October 8, 2021
CompletedFirst Posted
Study publicly available on registry
October 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedOctober 25, 2021
October 1, 2021
1.3 years
October 8, 2021
October 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
compare numbers of reintervention between groups
assessed by calculating the number of patients needed surgical reintervention per total number of patients in both groups
1 year
Study Arms (2)
Valve ablation
ACTIVE COMPARATORValve ablation
Valve ablation and bladder neck incision
ACTIVE COMPARATORValve ablation and bladder neck incision
Interventions
Valve ablation and bladder neck incision
Eligibility Criteria
You may qualify if:
- Patients who are less than 12 years of age with presenting to the Mansoura University Urology and Nephrology Center with the diagnosis of PUV will be s creended for eligibility
You may not qualify if:
- Patients with other conditions that can potentially affect lower and upper urinary tract functions
- Patients who were treated with urinary diversion as vesicostomy or cutaneous ureterostomy.
- Patients who had primary treatment of posterior urethral valve ablation at other hospitals.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Urology and nephrology center, Mansoura university
Al Mansurah, Dakahlia Governorate, 35516, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 8, 2021
First Posted
October 21, 2021
Study Start
October 1, 2021
Primary Completion
January 1, 2023
Study Completion
January 1, 2023
Last Updated
October 25, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share